LUXEMBOURG, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company, announced that its Chief Scientific Officer, Dr Maxim Skulachev, will give a full...
Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company, and Essex Bio-Technology, a China-based bio-pharmaceutical company, announced positive data from their VISTA-2 study (NCT04206020) – a U.S. randomized, double-blind, vehicle-controlled study of SkQ1 as treatment for Dry Eye Disease (DED).